Polaryx Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Polaryx Therapeutics, Inc. (PLYX) reported Basic Shares Outstanding (Weighted Average) of 48.28 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 48.28M shares, a 8.08% increase year-over-year.
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 47.22M shares, a 6.50% increase year-over-year.
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 44.67M shares.
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 44.34M shares.
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 45.42M shares, a 32.81% increase from fiscal 2024.
- Polaryx Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 34.20M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | 48.28M shares 10-Q · filed 2026-08-13 | 47.75M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 47.22M shares 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | 45.42M shares 10-K · filed 2026-03-24 | ||
| 2025-06-30 | 44.67M shares 10-Q · filed 2026-08-13 | 44.51M shares 10-Q · filed 2026-08-13 | |
| 2025-03-31 | 44.34M shares 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | 34.20M shares 10-K · filed 2026-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |